Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - An indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin

European Journal of Clinical Pharmacology

Volumn 56, Issue 2, 2000, Pages 123-127

  Von Bahr, C ^a   Ursing, C ^a   Yasui, N ^a   Tybring, G ^a   Bertilsson, L ^a   Rojdmark S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Citalopram; Fluvoxamine; Melatonin

Indexed keywords

CITALOPRAM; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 ISOENZYME; FLUVOXAMINE; MELATONIN; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; LIVER METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0034129702     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050729     Document Type: Article

References (31)

1. Anton-Tay F, Wurtman RJ (1969) Regional uptake of 3H-melatonin from blood or cerebrospinal fluid by rat brain. Nature 221: 474-475
2. Anton-Tay F, Diaz JL, Fernandez-Guardiola G (1971) On the effects of melatonin upon human brains, its possible therapeutic implications. Life Sci 10: 841-850
3. Arendt J (1992) The Pineal. In: Touitou Y, Haus E (eds) Biological rhythms in clinical and laboratory medicine. Springer, Berlin Heidelberg New York, pp 348-362
4. Beck-Friis J, Kjellman BF, Wetterberg L (1985) Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr Scand 71: 319-330
5. Brainard GC, Gaddy JR, Barker FM, Hanifin JP, Rollag MD (1993) Mechanisms in the eye that mediate the biological and therapeutic effects of light in humans. In: Wetterberg L (ed) Light and biological rhythms in man. Pergamon Press, Oxford, pp 29-53
6. Brzezinski A (1997) Melatonin in humans. New Engl J Med 336: 186-195
7. Carrillo JA, Dahl ML, Svensson JO, Alm C, Rodriguez I, Bertilsson L (1996) Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity. Clin Pharmacol Ther 60: 183-190
8. Demisch K, Demisch L, Bochnik HJ, Nickelsen T, Althoff PH, Schöffling K, Reith R (1986) Melatonin and cortisol increase after fluvoxamine. Br J Clin Pharmacol 22: 620-622
9. Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH (1994) Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA 91: 1824-1828
10. Frazer A, Brown R, Kocsis J, Caroff S, Amsterdam J, Winokur A, Sweeney J, Stokes P (1986) Patterns of melatonin rhythms in depression. In: Wurtman RJ, Waldhauser F (eds) Melatonin in humans. Springer, Berlin Heidelberg New York, pp 269-290
11. Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, Herer P, Tzischinsky O, Lavie P (1994) Sleep disorders and melatonin rhythm in elderly people. BMJ 309: 167
12. Hayes B, Czeisler CA (1992) Chronobiology of human sleep and sleep disorders. In: Touitou Y, Haus E (eds) Biological rhythms in clinical and laboratory medicine. Springer, Berlin Heidelberg New York, pp 256-264
13. Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brosen K (1996) Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, flurotamine and paroxetine. Eur J Clin Pharmacol 51: 73-78
14. Jeppesen U, Rasmussen BB, Brosen K (1997) Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chlorguanide. Clin Pharmacol Ther 62: 279-286
15. Jones RL, McGreer AC, Greiner AC (1969) Metabolism of exogenous melatonin in schizophrenic and non-schizophrenic volunteers. Clin Chim Acta 26: 281-285
16. Lang U, Kornemark M, Aubert ML, Paunier L, Sizonenko PC (1981) Radioimmunological determination of urinary melatonin in humans, correlation with plasma levels and typical 24-hour rhythmicity. J Clin Endocrinol Metab 53: 645-650
17. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP (1980) Light suppresses melatonin secretion in humans. Science 210: 1267-1269
18. Lieberman HR (1986) Behaviour, sleep and melatonin. In: Wurtman RJ, Waldhauser F (eds) Melatonin in humans. Springer, Berlin Heidelberg New York, pp 223-241
19. MacKay FJ, Dunn NR, Wilton LV, Pearce GL, Freemantle SN, Mann RD (1997) A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Saf 6: 235-246
20. Rasmussen BB, Nielsen TL, Brosen K (1998) Fluvoxamine inhibits the CYP2C19-catalyzed metabolism of proguanil in vitro. Eur J Clin Pharmacol 54: 735-740
21. Reiter RJ (1988) Neuroendocrinology of melatonin. In: Miles A, Philbrick DRS, Thompson C (eds) Melatonin. Clinical perspectives. Oxford University Press, Oxford, pp 1-42
22. Reiter RJ (1991) Pineal melatonin, cell biology of its synthesis and of its physiological interactions. Endocr Rev 12: 151-180
23. Röjdmark S, Berg A, Rössner S, Wetterberg L (1991) Nocturnal melatonin secretion in thyroid disease and in obesity. Clin Endocrinol 35: 61-65
24. Skene DJ, Bojkowski CJ, Arendt J (1994) Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans. Br J Clin Pharmacol 37: 181-186
25. Wetterberg L, Arendt J, Paunier L, Sizonenko PC, van Donselaar W, Heyden T (1976) Human serum melatonin changes during the menstrual cycle. J Clin Endocrinol Metab 42: 185-188
26. Wetterberg L, Eriksson O, Friberg Y, Vangbo B (1978) A simplified radio-immunoassay for melatonin and its application to biological fluids. Preliminary observations on the half-life of plasma melatonin in man. Clin Chim Acta 86: 169-177
27. Wikner J, Andersson DEH, Wetterberg L, Röjdmark S (1995) Impaired melatonin secretion in patients with Wernicke-Korsakoff syndrome. J Intern Med 237: 571-575
28. Wikner J, Hirsch U, Wetterberg L, Röjdmark S (1998) Fibromyalgia - a syndrome associated with decreased nocturnal melatonin secretion. Clin Endocrinol 49: 179-183
29. Vollrath L, Semm P, Gammel G (1981) Sleep induction by intra-nasal application of melatonin. Adv Biosci 29: 327-329
30. Wurtman RJ, Axelrod J, Fischer JE (1964) Melatonin synthesis in the pineal gland, effect of light mediated by the sympathetic system. Science 143: 1328-1330
31. Yu H, Tsin ATC, Reiter RJ (1993) Melatonin, history, biosynthesis and assay methodology. In: Yu HS, Reiter RJ (eds) Melatonin. Biosynthesis, physiological effects, and clinical applications. CRC Press, Ann Arbor, pp 495-512